描述
CDMO/CRO Safety Assessment and Quality Control Testing and Analysis Services
Cell and Gene Therapy
CDMO/CRO Safety Assessment and Quality Control Testing and Analysis Services
CDMO/CROs play an important role in the development and manufacturing of cell and gene therapies. Sequanta Technologies has developed a range of specialized assays and analytical services, such as cell bank and microbial strain identification, vector sequencing, cell genome stability analysis, cytokine and immune biomarker analysis, etc., and provides test reports in compliance with the GLP standards. With our comprehensive multi-omics platforms, we support partners for “CDMO+CRO” one-stop drug discovery services to accelerate the R&D process, and provide services that meet the quality standards for drug submissions and clinical trials. We have worked with leading partners on several IIT/registered clinical trials, supported 2 BLA/NDA submissions and dozens of IND submissions, and performed thousands of clinical sample tests.
Featured Services
Vector full-length sequencing - providing test reports in compliance with the GLP standards

Sequanta Technologies offers a wide range of vector full-length sequencing solutions based on Sanger, NGS and third generation sequencing,and has extensive experience in plasmids, lentivirus, adeno-associated virus, mRNA and other vector testing. We can provide product release test reports in accordance with GLP standards to meet the needs of IND application and commercial manufacture testing.

描述
Adventitious agent virus detection - covering human, rodent, bovine, porcine and other species

The service is based on high-throughput whole-genome sequencing, and accurately detects adventitious agent virus by mapping with the latest database. It fully covers the potential risk of contamination from human, rodent, bovine, porcine and other sources and is applicable to a wide range of sample types including cell banks, microbial strain banks, cell products, virus products and donor samples.

描述
Solutions
描述